SA

Syed Asmath Begum

Active Director Director DIN 10884011
DIN 10884011 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Syed Asmath Begum

Data last updated:

Syed Asmath Begum is a Director at Clinrt Clinical Solutions Private Limited (since 2025) and Director at Centennial Pharmaceuticals Private Limited (since 2024). The companies operate in Paper.

DIN 10884011
Primary Designation Director
Industry Paper
First Appointment 24 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Mar 20252025Active
Director24 Dec 20242024Active

Board colleagues of Syed Asmath Begum

Directorship timeline

Open interactive timeline →
Clinrt Clinical Solutions Private Limited
Centennial Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Syed Asmath Begum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Asmath Begum

Syed Asmath Begum currently holds 2 directorships: Clinrt Clinical Solutions Private Limited (Director, since 25 Mar 2025); Centennial Pharmaceuticals Private Limited (Director, since 24 Dec 2024).

Syed Asmath Begum was first appointed on 24 Dec 2024 as Director at Centennial Pharmaceuticals Private Limited. The most recent appointment on record is 25 Mar 2025 at Clinrt Clinical Solutions Private Limited.

The current boards of Syed Asmath Begum's companies include Syed Ghouse (Clinrt Clinical Solutions Private Limited), Shaik Ismail Saheb (Centennial Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available